Preliminary efficacy of telisotuzumab vedotin (Teliso-V) treatment in the 2L/3L setting in MET gene amplified ( MET Amp), c-Met protein overexpressing (c-Met OE), nonsquamous, non-small cell lung cancer (NSQ NSCLC): Retrospective analysis of LUMINOSITY

被引：3
|
作者：
Camidge, D. Ross
Goldman, Jonathan
Vasilopoulos, Athan
Ansell, Peter
Xia, Summer
Bolotin, Ellen
Looman, Jim
Ratajczak, Christine
Noon, Elysa
Lu, Shun
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT214
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT214
引用
收藏
页数：3
相关论文
共 37 条
  • [21] The Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysis
    Sa Ye
    Jiuke Li
    Ke Hao
    Jianping Yan
    Hongbin Zhou
    Scientific Reports, 6
  • [22] The Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysis
    Ye, Sa
    Li, Jiuke
    Hao, Ke
    Yan, Jianping
    Zhou, Hongbin
    SCIENTIFIC REPORTS, 2016, 6
  • [23] Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer
    Camidge, D. Ross
    Barlesi, Fabrice
    Goldman, Jonathan W.
    Morgensztern, Daniel
    Heist, Rebecca
    Vokes, Everett
    Spira, Alex
    Angevin, Eric
    Su, Wu-Chou
    Hong, David S.
    Strickler, John H.
    Motwani, Monica
    Dunbar, Martin
    Parikh, Apurvasena
    Noon, Elysa
    Blot, Vincent
    Wu, Jun
    Kelly, Karen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (05) : 1105 - +
  • [24] Efficacy and safety of MCLA-129, an EGFR/c-MET bispecific antibody, in advanced non-small cell lung cancer (NSCLC)
    Wang, Jie
    Zhong, Jia
    Wu, Lin
    Chen, Bolin
    Wang, Zhe-Hai
    Yao, Yu
    Dong, Xiaorong
    Li, Wei
    Ren, Xiubao
    Hou, Xiaoming
    Zang, Ai-min
    Qu, Xiujuan
    Zhang, Guojun
    Wang, Yongsheng
    Bai, Yuansong
    Liu, Linlin
    Yu, Guohua
    Chen, Xingwu
    Ding, Lieming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Consistency analysis of c-Met protein expression over time in patients with non-squamous non-small cell lung cancer
    Cortot, A. B.
    Dubois, R.
    Gregoire, V.
    Gibier, J-B.
    Labreuche, J.
    Deprez, V.
    Dubrulle, D.
    Chretien, T.
    Wasielewski, E.
    Behal, H.
    Feng, D.
    Lind, A.
    Ansell, P. J.
    Thiebaut, R.
    Hader, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S282 - S282
  • [26] Analysis of c-Met gene copy number by dual-color silver in situ hybridization (SISH) in non-small cell lung cancer (NSCLC)
    Wynes, Murry W.
    Dziadziuszko, Rafal
    Singh, Shalini
    Ranger-Moore, James
    Szostakiewicz, Barbara
    Dziadziuszko, Katarzyna
    Jassem, Jacek
    Hirsch, Fred R.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [27] Non-squamous, metastatic non-small cell lung cancer: Retrospective c-met overexpression testing, patient characteristics, and treatment patterns
    Cai, Mona H.
    Choi, Yookyung Christy
    Vasilopoulos, Athan
    Liede, Alexander
    Lindsey, Sidney
    Raskin, Leon
    Truong, Ethan
    Fricke, Jeremy
    Gruber, Stephen
    Ansell, Peter
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 429 - 429
  • [28] ANS014004, a novel small-molecule type II c-Met inhibitor effectively overcomes clinical-resistance MET mutations and exhibits antitumor activity in preclinical models of MET-amplified non-small cell lung cancer (NSCLC) and gastric cancer
    Li, Gong
    Shi, Hepeng
    Zhang, Peilong
    Li, Xiangqiu
    Lan, Wenli
    Li, Linna
    Chung, David
    Schaab, Kevin
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [29] Phase I Study of 2-or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non-Small Cell Lung Carcinoma
    Camidge, D. Ross
    Morgensztern, Daniel
    Heist, Rebecca S.
    Barve, Minal
    Vokes, Everett
    Goldman, Jonathan W.
    Hong, David S.
    Bauer, Todd M.
    Strickler, John H.
    Angevin, Eric
    Motwani, Monica
    Parikh, Apurvasena
    Sun, Zhaowen
    Bach, Bruce Allen
    Wu, Jun
    Komarnitsky, Philip B.
    Kelly, Karen
    CLINICAL CANCER RESEARCH, 2021, 27 (21) : 5781 - 5792
  • [30] Associations of C-MET Gene Copy with EGFR Mutation and Gene Copy in EGFR-Tyrosine Kinase Inhibitor (TKI) Untreated Non-Small Cell Lung Cancer (NSCLC)
    Bae, J. M.
    Jeon, Y. K.
    Kim, Y. T.
    Seo, J. W.
    Kim, Y. A.
    Chung, D. H.
    LABORATORY INVESTIGATION, 2010, 90 : 397A - 397A
1234